This review examines evidence linking calcium dysregulation after TBI to downstream neurodegenerative processes relevant to AD, with an emphasis on calcium-activated kinases (CDK5, GSK3β, PKC, CaMKII, ERK, and DYRK1A), phosphatases (PP2A and CaN), and proteases (calpains). This evidence concerns the gene GSK3B and Alzheimer disease.